TAS-102 and the quest for predictive biomarkers
ESMO Open
.
2017 Sep 21;2(4):e000263.
doi: 10.1136/esmoopen-2017-000263.
eCollection 2017.
Authors
Daphne L van der Velden
1
,
Frans L Opdam
2
,
Frans L Opdam
2
Affiliations
1
Department of Molecular Oncology, Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands.
2
Department of Clinical Pharmacology, Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Noord-Holland, Netherlands.
PMID:
29018579
PMCID:
PMC5623337
DOI:
10.1136/esmoopen-2017-000263
No abstract available
Keywords:
biomarkers; chemotherapy; lonsurf; tas-102.
Publication types
Editorial